Medovex Corp. Common Stock
MDVX
MDVX was delisted on the 15th of November, 2017.
9 hedge funds and large institutions have $152K invested in Medovex Corp. Common Stock in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
50% more funds holding
Funds holding: 6 → 9 (+3)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
13% less capital invested
Capital invested by funds: $174K → $152K (-$22K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$34.2K |
| 2 |
Fisher Asset Management
Camas,
Washington
|
+$32.1K |
| 3 |
BW
Bison Wealth
Atlanta,
Georgia
|
+$11.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.97K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.67K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FPF
FNY Partners Fund
New York
|
-$12K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.88K |
MDVX Hedge Fund Activity: Q2 2017 in Review
9 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Medovex Corp. Common Stock (MDVX) for Q2 2017, worth a combined $152K — down 13% from $174K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MDVX positions and 2 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $34.2K. The largest seller was FNY Partners Fund, exiting entirely with an estimated $12K sold.
- 9 institutional investors held Medovex Corp. Common Stock (MDVX) as of Q2 2017, up from 6 in Q1 2017.
- Funds reported $152K of Medovex Corp. Common Stock stock for Q2 2017, down 13% quarter-over-quarter.
- 5 funds opened new Medovex Corp. Common Stock positions in Q2 2017 and 2 closed out, a net change of +3 holders.
- The largest Medovex Corp. Common Stock buyer in Q2 2017 was Citadel Advisors, an estimated $34.2K added.
- The largest Medovex Corp. Common Stock seller in Q2 2017 was FNY Partners Fund, an estimated $12K sold.
Based on aggregated 13F filings for Q2 2017.